An Entity of Type: chemical substance, from Named Graph: http://dbpedia.org, within Data Space: dbpedia.org

1,4,6-Androstatriene-3,17-dione (ATD) is a potent irreversible aromatase inhibitor that inhibits estrogen biosynthesis by permanently binding and inactivating aromatase in adipose and peripheral tissue. It is used to control estrogen synthesis. ATD may cause a positive test for the anabolic steroid Boldenone, of which it is a possible metabolite and production contaminant. ATD is also prohibited in amateur and professional sports which forbids aromatase inhibitors. A related agent is exemestane (Aromasin).

Property Value
dbo:abstract
  • 1,4,6-Androstatriene-3,17-dione (ATD) is a potent irreversible aromatase inhibitor that inhibits estrogen biosynthesis by permanently binding and inactivating aromatase in adipose and peripheral tissue. It is used to control estrogen synthesis. ATD was present in some over-the-counter bodybuilding supplements until 2009, as well as Topical ATD solutions that work transdermally. The product was developed and commercialized in the dietary supplement market place by industry journeyman Bruce Kneller, who holds a United States Patent for use of the compound and related compounds (#7,939,517) and Gaspari Nutrition. ATD has many names in sports supplements including: 1,4,6 etiollochan-dione, 3, 17-keto-etiochol-triene, androst-1,4,6-triene-3,17-dione and many others. These all refer to CAS# 633-35-2. ATD may cause a positive test for the anabolic steroid Boldenone, of which it is a possible metabolite and production contaminant. ATD is also prohibited in amateur and professional sports which forbids aromatase inhibitors. A related agent is exemestane (Aromasin). (en)
dbo:casNumber
  • 633-35-2
dbo:chEBI
  • 131190
dbo:fdaUniiCode
  • 217A6T1V8N
dbo:pubchem
  • 104880
dbo:thumbnail
dbo:wikiPageID
  • 13480435 (xsd:integer)
dbo:wikiPageLength
  • 4738 (xsd:nonNegativeInteger)
dbo:wikiPageRevisionID
  • 1121637321 (xsd:integer)
dbo:wikiPageWikiLink
dbp:c
  • 19 (xsd:integer)
dbp:casNumber
  • 633 (xsd:integer)
dbp:chebi
  • 131190 (xsd:integer)
dbp:chemspiderid
  • 94659 (xsd:integer)
dbp:eliminationHalfLife
  • 172800.0 (dbd:second)
dbp:h
  • 22 (xsd:integer)
dbp:iupacName
  • -1013 (xsd:integer)
dbp:legalUsComment
  • Supplement (en)
dbp:metabolism
  • Hepatic (en)
dbp:molecularWeight
  • 282 (xsd:integer)
dbp:o
  • 2 (xsd:integer)
dbp:pregnancyUs
  • X (en)
dbp:pubchem
  • 104880 (xsd:integer)
dbp:routesOfAdministration
  • Oral (en)
dbp:smiles
  • O=C\4\C=C/[C@]3C (en)
dbp:stdinchi
  • 1 (xsd:integer)
dbp:stdinchikey
  • DKVSUQWCZQBWCP-QAGGRKNESA-N (en)
dbp:unii
  • 217 (xsd:integer)
dbp:verifiedrevid
  • 413468625 (xsd:integer)
dbp:watchedfields
  • changed (en)
dbp:wikiPageUsesTemplate
dct:subject
gold:hypernym
rdf:type
rdfs:comment
  • 1,4,6-Androstatriene-3,17-dione (ATD) is a potent irreversible aromatase inhibitor that inhibits estrogen biosynthesis by permanently binding and inactivating aromatase in adipose and peripheral tissue. It is used to control estrogen synthesis. ATD may cause a positive test for the anabolic steroid Boldenone, of which it is a possible metabolite and production contaminant. ATD is also prohibited in amateur and professional sports which forbids aromatase inhibitors. A related agent is exemestane (Aromasin). (en)
rdfs:label
  • 1,4,6-Androstatriene-3,17-dione (en)
owl:sameAs
prov:wasDerivedFrom
foaf:depiction
foaf:isPrimaryTopicOf
is dbo:wikiPageRedirects of
is dbo:wikiPageWikiLink of
is foaf:primaryTopic of
Powered by OpenLink Virtuoso    This material is Open Knowledge     W3C Semantic Web Technology     This material is Open Knowledge    Valid XHTML + RDFa
This content was extracted from Wikipedia and is licensed under the Creative Commons Attribution-ShareAlike 3.0 Unported License